On the Legitimacy of Cross-Border Pharmacy

IF 0.3 Q3 LAW
S. Rabinovitch
{"title":"On the Legitimacy of Cross-Border Pharmacy","authors":"S. Rabinovitch","doi":"10.29173/ALR1255","DOIUrl":null,"url":null,"abstract":"Cross-border sales of prescription drugs to U.S. patients by Canadian internet pharmacies have generated significant controversy in the U.S. and Canada. Violative of U.S. drug legislation and of Canadian professional codes of conduct, cross-border pharmacy has nonetheless flourished in response to strong demand and incomplete enforcement. Proponents laud the greater affordability of drugs for U.S. customers; opponents decry the practice as unsafe for U.S. patients, economically ill-advised, and ultimately contrary to Canadian interests. This article evaluates the safety arguments put forward by the U.S. Food and Drug Administration and others and concludes that these concerns, though valid, do not justify the current U.S. prohibition on prescription drug imports from Canada. Similarly, professional regulatory bodies' objections to the participation of Canadian doctors and pharmacists in cross-border pharmacy are misplaced. More compelling are the economic arguments against cross-border pharmacy, though even here opponents assume normative positions that should be explicitly defined and socially determined. Finally, however, the article acknowledges that Canada may be compelled by real-world circumstances to curtail cross-border pharmacy in order to safeguard domestic drug supplies.","PeriodicalId":54047,"journal":{"name":"ALBERTA LAW REVIEW","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2020-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ALBERTA LAW REVIEW","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29173/ALR1255","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"LAW","Score":null,"Total":0}
引用次数: 2

Abstract

Cross-border sales of prescription drugs to U.S. patients by Canadian internet pharmacies have generated significant controversy in the U.S. and Canada. Violative of U.S. drug legislation and of Canadian professional codes of conduct, cross-border pharmacy has nonetheless flourished in response to strong demand and incomplete enforcement. Proponents laud the greater affordability of drugs for U.S. customers; opponents decry the practice as unsafe for U.S. patients, economically ill-advised, and ultimately contrary to Canadian interests. This article evaluates the safety arguments put forward by the U.S. Food and Drug Administration and others and concludes that these concerns, though valid, do not justify the current U.S. prohibition on prescription drug imports from Canada. Similarly, professional regulatory bodies' objections to the participation of Canadian doctors and pharmacists in cross-border pharmacy are misplaced. More compelling are the economic arguments against cross-border pharmacy, though even here opponents assume normative positions that should be explicitly defined and socially determined. Finally, however, the article acknowledges that Canada may be compelled by real-world circumstances to curtail cross-border pharmacy in order to safeguard domestic drug supplies.
论跨境药房的合法性
加拿大互联网药店向美国患者跨境销售处方药在美国和加拿大引发了重大争议。尽管违反了美国药品立法和加拿大职业行为准则,跨境药房仍因需求旺盛和执法不力而蓬勃发展。支持者称赞美国消费者更容易负担药物;反对者谴责这种做法对美国患者不安全,经济上不明智,最终违背了加拿大的利益。本文评估了美国食品药品监督管理局和其他机构提出的安全论点,并得出结论,这些担忧虽然有效,但并不能证明美国目前禁止从加拿大进口处方药是合理的。同样,专业监管机构反对加拿大医生和药剂师参与跨境药房也是错误的。更令人信服的是反对跨境制药的经济论点,尽管即使在这里,反对者也采取了应该明确定义和社会决定的规范立场。然而,文章最后承认,加拿大可能会因现实情况而被迫减少跨境药房,以保障国内药品供应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
20.00%
发文量
2
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信